logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Cissy Kityo

joint clinical research centre
H指数:53
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Understanding Adolescent Anti-Retroviral Therapy Use in the BREATHER-Plus Trial: Qualitative Findings From South Africa and Uganda

理解BREATHER-Plus试验中青少年抗逆转录病毒疗法的使用：来自南非和乌干达的定性研究结果

Journal of the International AIDS Society
IF4.9
2026-09-230
OAAI
Londiwe Shandu; Stella Namukwaya; Tamlyn Carmin Seunanden; Nothando Ngwenya; Moherndran Archary; Cissy Kityo; Deborah Ford; Sarah L. Pett; Adeodata R. Kekitiinwa; Sarah Bernays; Janet Seeley; the BREATHER-Plus trial team
Dolutegravir as first- or second-line treatment for children living with HIV: 240-week follow-up of the ODYSSEY randomised trial

多替拉韦作为HIV感染儿童的初始或二线治疗方案：ODYSSEY随机试验240周的随访结果

Open Forum Infectious Diseases
IF3.8
2026-05-050
OA
Hilda Angela Mujuru, MMed, Prof; Ellen White, PhD; Adeodata R Kekitiinwa, MMed; Abbas Lugemwa, MD; Cissy Kityo, PhD; Avy Violari, FCPaed(SA); Grace Miriam Ahimbisibwe, MSc; Ebrahim Variava, FCP(SA); Moherndran Archary, PhD, Prof; Mark Cotton, PhD, Prof; Pradthana Ounchanum, MD; Thanyawee Puthanakit, MD; Suparat Kanjanavanit, MD; Chaiwat Ngampiyaskul, MD; Robin Kobbe, MD; Srini Bandi, FRCPCH; Cristina Epaiza, MD; Mutsawashe Bwakura-Dangarembizi, PhD; Dickson Bbuye, MBchB; Mariam Kasozi, BSc; Elizabeth Kaudha, MMed; Tim R Cressey, PhD; Carlo Giaquinto, MD, Prof; Lungile Jafta; Alasdair Bamford, PhD; Pablo Rojo, PhD; Diana M Gibb, MD, Prof; Anna Turkova, MD; Deborah Ford, PhD; null
Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study

人类免疫缺陷病毒感染者使用替诺福韦、拉米夫定和度鲁特韦启动或转换治疗时的病毒学及药物耐药性结局：一项前瞻性队列研究（在六个PEPFAR支持国家进行）

The Lancet HIV
IF0
2025-11-260
PRE
Jean Bernard Marc; Caitlyn McCarthy; Carole L Wallis; Cissy Kityo; Michael D Hughes; Catherine Godfrey; N Sarita Shah; Urvi M Parikh; Gary Maartens; Francis Kanyike; Marije Van Schalkwyk; Raymond Bernard Kihumuro; Philip Asiimwe; Isaac Tsikhutsu; Cornelius Munyanga; Fatma F Some; Yvetot Joseph; Tracy Flowers; Lerato Mohapi; Wadzanai P Samaneka
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial

卡博特格韦和利匹韦林治疗非洲艾滋病病毒感染：来自CARES 3b期随机、开放标签、非劣效性试验的96周结果

Nature Medicine
IF50
2025-11-040
OAAI
Cissy Kityo; Ivan K. Mambule; Joseph Musaazi; Simiso Sokhela; Henry Mugerwa; Ibrahim Yawe; Fiona Cresswell; Abraham Siika; Josphat Kosgei; Reena Shah; Logashvari Naidoo; Kimton Opiyo; Caroline Otike; Karlien Möller; Max Okwero; Charity Wambui; Veerle Van Eygen; Perry Mohammed; Fafa Addo Boateng; Nicholas I. Paton
Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial

每日一次的达芦那韦/拉米夫定固定剂量制剂在HIV感染者儿童中的应用：一项在开放标签、多中心、随机、非劣效性D3/PENTA 21试验中嵌套的药代动力学和安全性的子研究

eBioMedicine
IF10.8
2025-09-260
PREAI
Lisanne A.H. Bevers; Gabriela Toledo; Muzamil Kisekka; Elizabeth Kaudha; Grace M. Ahimbisibwe; Isabelle Deprez; Tiyara Arumugan; Ebrahim Variava; Avy Violari; Iona White; Dickson Bbuye; Annet Nanduudu; Enoch Mulwanyi; Pauline Amuge; Diana A. Rutebarika; Adeodata Kekitiinwa; Cissy Kityo; Philippa Musoke; Moherndran Archary; Justine Boles; Margaret J. Thomason; Saskia N. de Wildt; Carlo Giaquinto; Angela Colbers; David M. Burger; Ann M. Buchanan; Man K. Chan; Tom G. Jacobs; Anna Turkova
Pharmacokinetics of long-acting cabotegravir and rilpivirine in virologically suppressed adolescents living with HIV-1 in Sub-Saharan Africa: Data from the LATA trial

长效卡博格韦和 rilpivirine 在病毒学抑制的撒哈拉以南非洲 HIV-1 感染青少年中的药代动力学：来自 LATA 试验的数据

British Journal of Clinical Pharmacology
IF3
2025-09-030
PREAI
L. Bevers; E. Chappell; C. Kityo Mutuluuza; H. Mugerwa; M. Bwakura Dangarembizi; S. Weza; L. Diana Anena; M. Archary; M. Bush; A. Green; M. J. Thomason; D. Ford; A. R. Kekitiinwa; S. L. Pett; T. Jacobs; D. M. Burger
Africa is an Essential Partner in the Research and Development of an HIV Vaccine

非洲是HIV疫苗研究与开发的重要合作伙伴

CURRENT HIV RESEARCH
IF1
2025-09-010
PRE
Gray, Glenda; Williamson, Carolyn; Bekker, Linda-Gail; Daniels, Brodie; Smidt, Werner; Garrett, Nigel; Mutuluuza, Cissy Kityo; Mwesigwa, Betty; Stranix-Chibanda, Lynda; Akimbu, Alash'le; Obuku, Andrew; Johnson, Tian; Naluyima, Prossy; Sawe, Fredrick; Burgers, Wendy; Ntiginya, Nyanda; Morar, Neetha; Takalani, Azwidihwi; Hendricks, Simone; Woeber, Kubashni; Abrahams, Fatima; Tholanah, Martha; Mugamba, Stephen; Mulder, Michelle; Moore, Penny
Distinct Metabolic and Inflammation Signatures in Urban vs Rural Ugandan Youth With HIV on Dolutegravir

城市与农村乌干达青年HIV感染者中不同的代谢和炎症特征（接受多替拉韦治疗者）

OPEN FORUM INFECTIOUS DISEASES
IF3.8
2025-08-010
OAAI
Dirajlal-Fargo, Sahera; Sun, Shan; Ailstock, Kate; Cummings, Morgan; Lucas, Nate; Nazzinda, Rashida; Karungi, Christine; Oryem, Daisy Faith; Kidega, Robert; Musiime, Victor; Kityo, Cissy; McComsey, Grace A.; Funderburg, Nicholas
The imperative for increased investment for an HIV cure

加大投资以寻求艾滋病治愈的必要性

lancet hiv
IF0
2025-07-220
PRE
Remko van Leeuwen; Françoise Barré-Sinoussi; Michaela Müller-Trutwin; Asier Sáez-Cirión; Monique Nijhuis; Sharon R Lewin; Thumbi Ndung'u; Florence Riako-Anam; Mitchell Warren; Izukanji Sikazwe; Birgit Poniatowski; Beatriz Grinsztejn; Cissy Kityo; Masen Davis; Ole S Søgaard; Marcus Altfeld; Javier Martinez-Picado; Linos Vandekerckhove; Andrea Gramatica; Devin Sok; Simon Collins; Yazdan Yazdanpanah
Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites

替诺福韦-拉米夫定-多替拉韦在初治和病毒学抑制个体中，从基于NNRTI的方案转换后的病毒学结局：一项13个中心的观察性分析

OPEN FORUM INFECTIOUS DISEASES
IF3.8
2025-07-011
OAAI
Kityo, Cissy; McCarthy, Caitlyn; Koenig, Serena P.; Hughes, Michael D.; Wallis, Carole L.; Tsikhutsu, Isaac; Munyanga, Cornelius; Mwelase, Noluthando; Van Schalkwyk, Marije; Marc, Jean Bernard; Mponda, Kelvin; Dawson, Rodney; Some, Fatma F.; Mohapi, Lerato; Joseph, Yvetot; Parikh, Urvi M.; Shah, N. Sarita; Manabe, Yukari C.; Godfrey, Catherine; Woolley, Elizabeth; Mellors, John W.; Flexner, Charles
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial

在非洲病毒抑制的HIV成人患者中改用长效cabotegravir和利比韦林 (CARES): 随机，多中心，开放标签，非劣效性试验的48周结果

LANCET INFECTIOUS DISEASES
IF31
2024-10-0115
PRE
Kityo, Cissy; Mambule, Ivan K.; Musaazi, Joseph; Sokhela, Simiso; Mugerwa, Henry; Ategeka, Gilbert; Cresswell, Fiona; Siika, Abraham; Kosgei, Josphat; Shah, Reena; Naidoo, Logashvari; Opiyo, Kimton; Otike, Caroline; Moller, Karlien; Kaimal, Arvind; Wambui, Charity; Van Eygen, Veerle; Mohammed, Perry; Boateng, Fafa Addo; Paton, Nicholas, I
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium
LANCET HIV
IF13
2024-10-011
PRE
Kuhn, Louise; Barnabas, Shaun; Cotugno, Nicola; Peay, Holly; Goulder, Philip; Cotton, Mark; Violari, Avy; Pahwa, Savita; Reddy, Kavidha; Tagarro, Alfredo; Otwombe, Kennedy; Fry, Samantha; Vaz, Paula; Lain, Maria Grazia; Nhampossa, Tacilta; Archary, Moherndran; Maiga, Almoustapha Issiaka; Puthanakit, Thanyawee; Kityo, Cissy M.; Foster, Caroline; Rojo, Pablo; Klein, Nigel; Nastouli, Eleni; Tiemessen, Caroline T.; de Rossi, Anita; Ndung'u, Thumbi; Persaud, Deborah; Lichterfeld, Mathias; Giaquinto, Carlo; Palma, Paolo; Rossi, Paolo
A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion

用于基于电阻抗评估红细胞介导的微血管闭塞的小型化免清洗微流控测定

BIOSENSORS & BIOELECTRONICS
IF10.5
2024-08-010
PRE
Oshabaheebwa, Solomon; Delianides, Christopher A.; Patwardhan, Akshay A.; Evans, Erica N.; Sekyonda, Zoe; Bode, Allison; Apio, Faith M.; Mutuluuza, Cissy K.; Sheehan, Vivien A.; Suster, Michael A.; Gurkan, Umut A.; Mohseni, Pedram
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With Human Immunodeficiency Virus From 6 Countries
CLINICAL INFECTIOUS DISEASES
IF7.3
2024-05-131
PRE
Shah, N. Sarita; Kityo, Cissy; Hughes, Michael D.; Mccarthy, Caitlyn; Wallis, Carole L.; Hosseinipour, Mina C.; Langat, Deborah; Nyirenda, Mulinda; Rassool, Mohammed; Dawson, Rodney; Joseph, Yvetot; Some, Fatma; Mngqibisa, Rosie; Mukwekwerere, Pamela Grace; Woolley, Elizabeth; Godfrey, Catherine; Manabe, Yukari C.; Mellors, John W.; Flexner, Charles
Specific plasma microRNAs are associated with CD4+ T-cell recovery during suppressive antiretroviral therapy for HIV-1

在HIV-1的抑制性抗逆转录病毒治疗期间，特定的血浆microrna与CD4 T细胞恢复有关。

AIDS
IF3.1
2024-02-010
OAAI
Kroeze, Stefanie; Kootstra, Neeltje A.; van Nuenen, Ad C.; Rossouw, Theresa M.; Kityo, Cissy M.; Siwale, Margaret; Akanmu, Sulaimon; Mandaliya, Kishor; de Jager, Marleen; Ondoa, Pascale; Wit, Ferdinand W.; Reiss, Peter; de Wit, Tobias F. Rinke; Hamers, Raph L.

研究方向

暂未获取到该数据
T
Tobias F. Rinke de Wit
H 指数:51论文数:253被引数:8,358
P
Peter Mugyenyi
H 指数:48论文数:208被引数:8,826
R
Raph L Hamers
H 指数:47论文数:233被引数:8,433
K
Kim Sigaloff
H 指数:40论文数:158被引数:1.1万
D
Diana M. Gibb
H 指数:66论文数:612被引数:1.9万
M
Margaret Siwale
H 指数:19论文数:43被引数:1,701
K
Kishor Mandaliya
H 指数:30论文数:145被引数:2,893
W
Wendy Stevens
H 指数:66论文数:407被引数:2.0万
C
Chris T. Longenecker
H 指数:33论文数:233被引数:4.3万
A
A. Sarah Walker
H 指数:82论文数:519被引数:2.8万